There is one clinical trial.
Open label two arms, non randomized Convalescent Plasma treatment to severe and critical pneumonia COVID-19 hospitlaized patients compared to a historical cohort with matched controls.
Description: progression to critical stage
Measure: INCIDENCE OF CRITICAL PNEUMONIA Time: 14 days after convalescent plasma administrationDescription: mortality
Measure: MORTALITY RATE AMONG CRITICAL PNEUMONIA PATIENTS Time: 28 days after convalescent plasma administrationDescription: time to need mechanical ventilation
Measure: INCIDENCE OF MECHANICAL VENTILATION Time: 14 days after convalescent plasma treatmentDescription: time of mechanical ventilation needed
Measure: DAYS OF MECHANICAL VENTILATION Time: 28 days after convalescent plasma treatment